About Avertix
Avertix is a Healthcare company based in Eatontown (United States) founded in 2001 by David Fischell. An implantable warning system for heart attack detection is provided. It operates in the Healthcare and Technology sectors. Avertix has raised $22.36 million across 6 funding rounds from investors including HHS. The company has 31 employees. Its chief executive, as recorded, is Timothy P Moran. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its legal entity is ANGEL MEDICAL SYSTEMS, INC. Its competitors include iRhythm Tech, AliveCor and Imperative Care; 3 of its 3 listed competitors have raised funding.
Company details
Avertix was founded in 2001 and is headquartered in Eatontown, United States. The company operates in the medical device sector, focusing on cardiology solutions. An implantable patient alerting system, known as the Guardian System, is developed to detect and warn about Acute Coronary Syndrome, including silent heart attacks. Patients are notified to seek medical attention through this technology.
- Headquarters Eatontown, United States
- Employees 31
- Founders David Fischell
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website avertix.com
- Social LinkedIn X
- Legal Name Angel Medical Systems, Inc.
- Total Equity Funding$22.36M (USD)
in 6 rounds
- Latest Funding Round$1.01M (USD), Series B
Sep 2025
- Investors
- Employee Count31
Funding Insights of Avertix
Avertix has successfully raised a total of $22.36M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $1.01 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $22.36M
- Total Rounds 6
- Last Round Series B — $1.01M
- First Round $3.45M
(Jul 2009)
- Investors Count 1
All 6 funding rounds of Avertix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Avertix
Avertix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Avertix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avertix
2 people are tracked at Avertix (2 in leadership); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
David Fischell | Co-Founder | Leadership |
Timothy P Moran | CEO & President | Leadership |
Complete people profiles for Avertix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avertix
3 dated milestones of Avertix across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Avertix is founded.
- Funding First funding round of $3.4M.
- Funding Latest funding round, Series B, of $1.0M.
Competitors of Avertix
Avertix has 3 listed competitors in our database, 3 of them funded. They include iRhythm Tech, AliveCor and Imperative Care.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| irhythmtech.com | 2006 | San Francisco, United States | $109.23M | 1,657 | Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | |
| alivecor.com | 2010 | Mountain View, United States | $114.38M | 67 | Cardiac monitoring devices and applications are provided for heart health. | |
| imperativecare.com | 2015 | Campbell, United States | $496M | 90 | Access catheters for neurovascular stroke treatment are provided. |
Detailed competitors of Avertix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avertix
The website of Avertix (avertix.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 7.5% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Avertix (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avertix
Complete news archive for Avertix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avertix
Avertix was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Avertix is headquartered in Eatontown, United States. It is registered at Eatontown, New Jersey, United States.
Timothy P Moran is the CEO of Avertix, as recorded in our data.
Avertix is a funded company, having raised a total of $22.36M across 6 funding rounds to date. The company's 1st funding round was a Grant of $3.45M, raised on Jul 2009.
Avertix has 31 employees.
Avertix was founded in 2001 and is headquartered in Eatontown, United States. The company operates in the medical device sector, focusing on cardiology solutions. An implantable patient alerting system, known as the Guardian System, is developed to detect and warn about Acute Coronary Syndrome, including silent heart attacks. Patients are notified to seek medical attention through this technology.
Avertix's top competitors include AliveCor, iRhythm Tech and Imperative Care.
Avertix has 1 investor. Key investors include HHS.
Avertix operates through Angel Medical Systems, Inc..